| Financial Year |
March 31 2021 |
| Monetary Funds |
126,925,923.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
925,244.03 |
| Advances to Suppliers |
-- |
| Other Receivables |
47,996,053.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
14,704,594.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,327,465.12 |
| Total Current Assets |
265,879,280.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
86,628,421.49 |
| Under-construction Projects |
9,571,370.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,597,747.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
22,948,719.80 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
249,746,258.91 |
| Total Assets |
515,625,538.97 |
| Short-Term Loans |
84,717,457.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
31,553,520.31 |
| Accounts Received In Advance |
1,636,857.74 |
| Employee Compensation Payable |
20,739,329.13 |
| Taxes Payable |
12,964,145.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
392,330,456.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
543,941,766.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
389,999.88 |
| Total Liabilities |
544,331,766.74 |
| Paid-In Capital(Or Share Stock) |
771,844,628.00 |
| Capital Surplus |
1,426,295,064.43 |
| Surplus Reserve |
18,581,177.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,243,648,422.62 |
| Minority Stockholder's Interest |
-1,778,675.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-26,927,552.54 |
| Owner's Equity（Stockholder's Equity） |
-28,706,227.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
515,625,538.97 |
